News
-

NAD+ vs NADH: What Is the Difference?
NAD+ accepts electrons; NADH carries them. Their relationship explains cell chemistry, but it does not establish which product would help a person.
-

Tesamorelin Carpal Tunnel: Why Hands May Tingle
Tesamorelin can cause swelling that presses on a wrist nerve. The trial rates, symptom pattern, and clinical exam help explain hand tingling without assuming its cause.
-

Thymosin Alpha 1 Myths: 10 Claims Checked
Thymosin alpha-1 can change immune-cell signals. Ten evidence grades explain why that does not establish infection prevention, longer survival or interchangeable products.
-

Semax Selank and Antidepressants: Can They Mix?
The combination's safety hasn't been established in people. A rat study and small Selank comparisons answer narrower questions than whether the pair fits an antidepressant prescription.
-

MOTS-c vs CB4211: Related, Not Interchangeable
CB4211 is a modified relative of MOTS-c. Its early human trial cannot establish a MOTS-c dose, side-effect rate, or expected result.
-

Saxenda Prescribing Information, in Plain English
Saxenda is a daily liraglutide medicine for weight management. Its label has different dose checks for adults and teenagers, plus warnings that matter at any age.
-

10 Questions to Ask Before DSIP
Ten questions about sleep history, breathing, medicines, past treatment, and expectations that help a provider assess a DSIP request.
-

Should I Take Semax Selank? What a Provider Weighs
A provider starts with your symptoms and current treatment. Small studies of the separate peptides don't settle whether the pair fits you.
-

WOMAC Score Meaning: What the Numbers Tell You
WOMAC tracks arthritis pain, stiffness and daily movement. Its scale matters: a score change describes symptoms, and doesn't prove joint repair.
-

CJC-1295 Ipamorelin Blood Sugar: Can It Rise?
The pair's blood sugar risk has no reliable human percentage. The short studies offer useful context for a conversation about diabetes, medicines and monitoring.
-

Wolverine Peptide Myths: 10 Claims Checked
Animal comparisons and small human reports exist. Neither establishes that the BPC-157 and TB-500 blend improves human recovery or works better than either ingredient alone.
-

PT-141 Skin Darkening: Can the Patches Last?
PT-141 can cause patches of darker skin or gums. The Vyleesi studies show a real pigment signal, with uncertainty about complete fading.
-

Cold Weather Medication Delivery: Freeze Concerns
A prescription left outside in the cold is not automatically ruined. Suspected freezing needs the dispensing pharmacy's review of the product and its journey.
-

GLP-1 Prior Authorization Denied? What Comes Next
The denial reason decides the next step: missing records, an unmet coverage rule, or an excluded benefit. An appeal needs to address that specific issue.
-

Does Semaglutide Cause Bone Loss? What We Know
Bone density can fall during semaglutide-related weight loss. New reviews and the Wegovy label explain why fracture risk needs a more individual answer.
-

GHK-Cu Injection vs Topical: What Studies Show
Creams, serums and wound gels account for most human evidence. Injections haven't been shown to work better, and skin absorption isn't the same as benefit.
-

Thymosin Alpha 1 Hepatitis B: Mixed Trial Results
A Taiwan trial found a delayed improvement in viral blood markers. A U.S. study using an inactive comparison treatment did not confirm a clear benefit.
-

BPC-157 for Back Pain: What the Studies Show
No human trial has tested BPC-157 for back pain. Rat spinal-cord experiments and medical-record reports of human use answer different questions.
-

Can You Take Ibuprofen With Tirzepatide? Key Risks
The labels don't name ibuprofen as an interaction. Dehydration, kidney disease, ulcers, and other medicines can still change the answer.
-

DSIP vs Melatonin: What the Sleep Evidence Shows
Melatonin signals nighttime. DSIP's human sleep evidence is small and mixed, and no human sleep trial shows it works better.
Page 2 of 27 · 528 articles